ACQUISITION OF PLUVICTO AND LUTATHERA FOR RADIOLOGY PATIENTS.

PURCHASE ORDER won by NOVARTIS PHARMACEUTICALS CORPORATION · work in BETHESDA, MD
$578,754
RecipientNOVARTIS PHARMACEUTICALS CORPORATION UEI NG61ZA8TADW3
Award IDHT001426PE027
Award amount$578,754
Award typePURCHASE ORDER
Awarding agencyDepartment of Defense — Defense Health Agency
NAICS325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC6550
Set-asideUnrestricted
Start dateJan 15, 2026
End dateJan 15, 2026
Place of performanceBETHESDA, MD
Record updatedJan 12, 2026

View the official award record

More awards won by NOVARTIS PHARMACEUTICALS CORPORATION

ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF
Department of Health and Human Services · $16,334,775 · Sep 14, 2017
CLIN 2001AA AND CLIN 2001AB
Department of Defense · $5,369,485 · Oct 1, 2026
PLUVICTO
Department of Veterans Affairs · $4,732,608 · Feb 24, 2026
PLUVICTO AND LUTATHERA
Department of Veterans Affairs · $4,299,447 · Nov 1, 2025
LU177 - PLUVICTO/LUTATHERA
Department of Veterans Affairs · $4,162,659 · Feb 7, 2026

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids